Article Information
History
- August 25, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Stephen K. Dolan1,*,
- Andre Wijaya2,
- Michael Kohlstedt3,
- Lars Gläser3,
- Paul Brear4,
- Rafael Silva-Rocha5,
- Christoph Wittmann3 and
- Martin Welch4,*
- 1School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA 30332; Emory–Children’s Cystic Fibrosis Center, Atlanta, GA 30322; Center for Microbial Dynamics and Infection, Georgia Institute of Technology, Atlanta, GA 30332.
- 2Centre for Targeted Protein Degradation, University of Dundee, Dow Street, Dundee, DD1 5EH, Scotland, United Kingdom
- 3Institute of Systems Biotechnology, Saarland University, Saarbrücken, Germany
- 4Department of Biochemistry, University of Cambridge, United Kingdom
- 5Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Brazil
- ↵*Authors to whom correspondence should be addressed. MW (mw240{at}cam.ac.uk), SKD (sdolan31{at}gatech.edu)